• home
  • about
  • events
  • news
  • members
  • corporate members
  • contact

Become a corporate partner

Support as a Corporate Member is vital to the continued advancement of OSMO interests. With your support, OSMO will continue to be the leading professional organization for oncologists in the state of Oregon and a resource for the oncology community through professional education, and information dissemination.

Please contact Liz Cleland at osmoLIZ@comcast.net or 360.258.0443 for more information.

Latest Corporate Member News entries

  • FDA Approval: Important update to the VELCADE(r) (bortezomib) Prescribing Information
    Feb 14th, 2012
  • Effective for dates of service on or after January 1, 2012, the new J-code for both Prolia® and XGEVA® is J0897
    Dec 8th, 2011
  • Important Update: New HCPCS J-Code Effective January 1, 2012
    Dec 8th, 2011
  • Genomic Health Announces Medicare Coverage for Oncotype DX® Colon Cancer Test
    Oct 4th, 2011
  • ABRAXANE® for Injectable Suspension
    Aug 4th, 2011

Diamond Partners

  • 'AmgenAmgen
  • 'CelgeneCelgene
  • 'CephalonCephalon
  • 'LillyLilly
  • 'GenetechGenetech
  • 'MillenniumMillennium
  • 'Novartis OncologyNovartis Oncology
  • 'Pfizer OncologyPfizer Oncology

Gold Partners

  • 'Bayer Healthcare Pharmaceuticals/OnyxBayer Healthcare Pharmaceuticals/Onyx
  • 'Bristol-Myers SquibbBristol-Myers Squibb
  • 'Centocor Ortho BiotechCentocor Ortho Biotech
  • 'Eisai, Inc.Eisai, Inc.
  • 'Genomic HealthGenomic Health
  • 'McKesson Specialty Care SolutionsMcKesson Specialty Care Solutions
  • 'MerckMerck
  • 'Oncology Supply/IONOncology Supply/ION
  • 'Prometheus LabsPrometheus Labs
  • 'Sanofi AventisSanofi Aventis
  • 'Seattle GeneticsSeattle Genetics
  • 'Spectrum PharmaceuticalsSpectrum Pharmaceuticals

Silver Partners

  • Allos Therapeutics Inc
  • AstraZeneca Pharmaceuticals
Oregon Society of Medical Oncology (OSMO)
Copyright © 2012. All rights reserved.